Stay updated with breaking news from Patient Access Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with
Patients are seeing the first savings from drug price reforms included in the Inflation Reduction Act. Patients are seeing the first savings from drug price reforms included in the Inflation Reduction Act.
With Election Day on the horizon, the president is trying to make sure voters know who was responsible.
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010. The drugs h...
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with